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Background: Electroconvulsive therapy (ECT) has been shown to induce broadly distributed cortical and
subcortical volume increases, more prominently in the amygdala and the hippocampus. Structural
changes after one ECT session and in the long-term have been understudied.
Objective: The aim of this study was to describe short-term and long-term volume changes induced in
cortical and subcortical regions by ECT.
Methods: Structural brain data were acquired from depressed patients before and 2 h after their first ECT
session, 7e14 days after the end of the ECT series and at 6 months follow up (N ¼ 34). Healthy, age and
gender matched volunteers were scanned according to the same schedule (N ¼ 18) and patients affected
by atrial fibrillation were scanned 1e2 h before and after undergoing electrical cardioversion (N ¼ 16).
Images were parcelled using FreeSurfer and estimates of cortical gray matter volume and subcortical
volume changes were obtained using Quarc.
Results: Volume increase was observable in most of gray matter regions after 2 h from the first ECT
session, with significant results in brain stem, bilateral hippocampi, right putamen and left thalamus,
temporal and occipital regions in the right hemisphere. At the end of treatment series, widespread
significant volume changes were observed. After six months, the right amygdala volume was still
significantly increased. No significant changes were observed in the comparison groups.
Conclusions: Volume increases in gray matter areas can be detected 2 h after a single ECT session. Further
studies are warranted to explore the underlying molecular mechanisms.
© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The efficacy of electroconvulsive therapy (ECT) in the treatment
of severe mood disorders has been repeatedly confirmed and has
been widely recognized in international guidelines. However, it is
still not clear which mechanisms underlie response to ECT.and Visualization Centre,
ital, Bergen, Norway.
r Inc. This is an open access articleGeneralized and repeated seizures, likely affecting centrencephalic
and prefrontal regions, may represent a necessary, yet not sufficient
condition for ECT efficacy, as early suggested by the efficacy of
chemically induced generalized seizures and the positive associa-
tions between ictal EEG indices and therapeutic outcomes [1,2].
While both bitemporal and high-dose right unilateral ECT have
showed the same efficacy, low- and moderate-dose unilateral
stimulation, which also produce generalized seizures, are less
effective [3,4]. More recently, current paths and density have
gained more attention and the recruitment of a sufficiently largeunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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been hypothesized to underlie ECT antidepressant efficacy [5,6].
Several biological models have been proposed to explain the
clinical effects of ECT. The main current theories of the mechanism
of ECT could be subsumed into at least three different, although
partially overlapping, classes, based on the relevance which is
respectively given to: 1) changes in neurotransmission and endo-
crine signals induced by diencephalic stimulation [1,7,8]; 2)
changes in inflammation cascade in the CNS via immune system
modulation [9e11]; 3) induced neurotrophic effects, including
neurogenesis, synaptogenesis, angiogenesis, glial cell proliferation
[1,11,12].
Studies mainly conducted in animal models of electroconvulsive
stimulation (ECS) demonstrated that electrically induced seizures
can increase hippocampal neurogenesis and synaptogenesis,
induce vascular growth and glial cell proliferation, and modulate
BDNF expression [11e15]. Human studies, although underpowered
and heterogenous, consistently showed higher amygdala and hip-
pocampus volumes after a series of ECT treatments [16], and oc-
casionally volume increases in the anterior cingulate gyrus, insula
and temporal cortex were shown [17]. More recently, cortical and
subcortical volume increases after an ECT course were found to be
broadly distributed across the brain in a mega-analysis of 328
depressed patients through the Global ECT-MRI Research Collabo-
ration (GEMRIC) [18]. Interestingly, changes were maximal in the
amygdala and the hippocampus and were prominent in regions
closest to the temporal electrodes. Further, they were positively
associated with the number of ECT treatments and were greater in
subcortical regions in patients receiving bilateral stimulation, but
no association was found with clinical outcome [18]. As the author
suggested, “despite co-occurring neuroplastic and molecular ef-
fects, only the molecular effects may be a key mechanism under-
lying the therapeutic success of ECT”, with volume increases
possibly representing an epiphenomenon [18] and largely
explained by the magnitude of the electrical field [19].
On the other hand, volume changes induced immediately after
one ECT session have been understudied. Previous studies found
significantly increased hippocampus and amygdala volumes bilat-
erally after the second ECT session, with further increases in vol-
umes after the end of ECT treatment [20], while no significant
changes in cortical thickness or subcortical volumeswere found nor
after the first [21] or the second ECT session [22,23]. In order to
evaluate whether widespread volume increases were present
immediately after a single ECT session and whether they persisted
in the long-term after a series of treatments, depressed patients
receiving ECT were recruited and scanned before (N¼ 34) and after
(N ¼ 33) their first session, 7e14 days after the end of series
(N ¼ 29) and at 6 months follow up (N ¼ 22).
2. Materials and methods
2.1. Participants, ECT procedure and assessments
The study protocol has been detailed elsewhere [24], a brief
summary is given here. Patients were recruited among individuals
accepted for ECT at Haukeland University Hospital, Bergen, Norway.
Eligibility required patients to be adults (age >18 years), referred to
the ECT-unit and accepted for treatment because of moderate or
severe depressive episode with a score 25 on the Montgomery
and Åsberg Depression Rating Scale (MADRS), both unipolar and
bipolar depressive disorder. ECT treatment within the last 12
months, pregnancy, inability to give written informed consent
(according to the responsible clinician or ECT responsible) and1331contraindications to MRI were considered as exclusion criteria.
During the study period, 352 ECT series were performed at our
treatment unit. All patients were screened for participation in the
study. The main reasons for non-inclusion were technical (MRI not
available) or meeting one of the exclusion criteria. Of patients who
were eligible and asked for inclusion, 27 did not want to participate
in the study. Out of 34 included patients who completed the
baseline MRI 22 also completed the MRI at the 6 months follow up
time point.
ECT was administered with a Thymatron System IV (Somatics
LLC, Venice, FL, USA) providing brief-pulse (0.5 ms), square wave,
constant current. All patients received treatment with right uni-
lateral electrode positioning (RUL). However, one patient was
transitioned to bitemporal ECT after 14 treatments because initial
RUL sessions were not effective. Anesthesia was obtained with the
short acting anesthetic thiopental and succinylcholine was used for
muscular blockade. The initial stimulus energy was determined
based on age and gender. The initial charge was determined by an
age-basedmethodwith patient's age in years x 5y stimulus charge
expressed in millicoulombs (mC). In order to consider gender
specific differences in seizure threshold, the % Energy was adapted
as following: For male patients: % Energy þ5e10%. For female pa-
tients: % Energy 5 to 10%. Usually, three sessions per week were
given until clinical remission.
Healthy, age and gender matched volunteers were recruited for
repeated magnetic resonance imaging (MRI) to account for
repeated measurements/time effects on imaging parameters. To
control for the potential effect of anesthesia on MRI, patients
receiving propofol for electrical cardioversion (ECV) for atrial
fibrillation were recruited.
Depressed patients received MRI scanning at four separate time
points: 1e2 h before (median ¼ 8:00 a.m., T1, N ¼ 34) and 1e2 h
after the first ECT session (median ¼ 12:00 p.m., T2, N ¼ 33), 7e14
days after the end of the ECT series (T3, N ¼ 29) and at follow-up 6
months after (T4, N ¼ 22). Data from T1 and T3 scans of ECT pa-
tients were previously included in GEMRIC mega-analysis [18].
Healthy controls (HC) were scanned four times at intervals similar
to the patients (N¼ 18 at T1-T2, N¼ 16 at T3-T4). Patients receiving
ECV (N ¼ 16) were scanned twice: before (median ¼ 8:50 a.m.) and
after ECV (median ¼ 3:15 p.m.).
Clinical evaluations for patients receiving ECT were performed
at baseline, T3 and T4. Depression severity was estimated using
MADRS. Cognitive side effects were assessed using the Everyday
Memory Questionnaire (EMQ), a self-reported inventory of sub-
jective memory complaints, and consistency scores based on the
Autobiographical Memory Interview-Short Form (AMI-SF), as pre-
viously detailed [25].
All participants provided written informed consent and the
study were approved by the Regional Committee for Medical and
Health Research Ethics, REC South East, Norway (2013/1032).
2.2. Image acquisition and processing
Structural data were acquired on a 3 T Discovery MR750 system
with 32-channel head coil. The protocol included a T1-weighted
fast spoiled gradient echo, FSPGR (TE/TR ¼ 2.9/6.7 ms;
TI ¼ 600 ms, flip angel ¼ 8; FOV ¼ 25.6 cm; voxel
size ¼ 1.0  1.0  1.0 mm3, acquisition time ¼ 10:32 min). Seven
ECT patients and one HC were scanned on a 3 T GE Signa HDxt
equipped with an 8-channel head coil. The protocol included a T1-
weighted inversion recovery spoiled gradient echo sequence, IR
SPGR (TE/TR ¼ 2.8/6.5 ms; TI ¼ 450 ms; flip angle ¼ 8; FOV
256 mm; voxel size ¼ 1.0  1.0  1.0 mm3). Images were corrected
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processed using automated FreeSurfer preprocessing steps (version
5.3; surfer.nmr.mgh.harvard.edu/), which includes segmentation of
subcortical white matter, deep gray matter structures and auto-
mated parcellation of the cerebral cortex [27e30]. Unbiased,
within-subject assessment of longitudinal changes of regional
brain volumes was performed using Quarc [31e33]. The image
processing pipeline corrects for scanner-specific distortions [26]
and maximizes power for longitudinal change estimation while
avoiding bias [33e35]. Estimates of relative volume change (%)
between T1 and T2, T3 and T4, were respectively obtained for each
region of interest (ROI) for each subject.
2.3. Statistical analysis
Differences between depressed patients and HC in age and
gender were first checked, respectively using two samples t-test,
after normality check using Shapiro-Wilk, and chi-squared test.
Single sample t-tests were conducted to determine if volume
change estimates at T2, T3 and T4 were statistically significantly
different from 0 in each of the groups for each of the ROIs. Since
single sample t-tests were performed on intra-individual volume
change estimates, no between-subject nuisance variable was
considered. False discovery rate (FDR) correction for multiple
comparisons was applied.
Significant changes were then compared among the groups
using analysis of variance (ANOVA) with Tukey's honest signifi-
cance test for post-hoc analysis at T2 and two-sample t-tests at T3
and T4.
In addition, we tested whether volume changes observed in ECT
patients at T3 could be predicted by changes at T2 using three
different linear models for each regionwith the following variables
included as predictors: i) volume changes at T2 (unadjusted
model); ii) volume changes at T2, number of ECT sessions (adjusted
model); iii) volume changes at T2, number of ECT sessions and the
interaction between these predictors (interaction model). A linear
model was also used to test whether volume changes in ECT pa-
tients at T4were predicted by changes at T3, without controlling for
other variables. False discovery rate (FDR) correction for multiple
comparisons was again applied to linear models.
Cross-sectional comparisons between depressed patients and
HC ROIs’ volumes were performed at each time point using a linear
model of ROI volume with group, age, gender, total intracranial
volume and scanner as predictors, applying false discovery rate
(FDR) correction.
Finally, for the ROIs with significant longitudinal volume
changes, we performed post-hoc exploratory correlation analyses
between i) volume change and change in depression severity
(MADRST3eT1, MADRST4eT1), ii) volume change and changes in
subjective memory complaints (EMQT3eT1, EMQT4eT1) and iii) vol-
ume change and autobiographical memory (AMI-SF consistencyT3,
AMI-SF consistencyT4) by using linear regression models both with
and without the total number of ECT sessions as a predictor. Spe-
cifically, volume changes were correlated with MADRS change,
EMQ change and AMI-SF consistency at T3 for ROIs with significant
volume change between T1 and T2 or T3, and at T4 for ROIs with
significant changes between T1 and T4.
Since MRI data from four patients and one HC were acquired
with different devices at T1 and T4, those subjects were excluded
from all the analyses on volume change estimates at T4. Results
associated with p < 0.05 were considered significant. All statistical1332analyses were performed using R Statistical Software, version 3.6.0
(Foundation for Statistical Computing, Vienna, Austria).
3. Results
3.1. Samples characteristics
Depressed patients and HC did not differ significantly in age
(46.42 ± 15.18 vs. 42.83 ± 15.88, t ¼ 0.79, p ¼ 0.44) and in gender
(females 18/34, 53%, vs. 11/18, 61%, c2 ¼ 0.07, p ¼ 0.79). ECV con-
trols were more frequently males (females 1/16, 6.3%, c2 ¼ 8.18,
p ¼ 0.004) and older aged (mean ± SD ¼ 66.50 ± 6.3, t ¼ 6.22,
p < 0.001) in comparison with depressed patients included in the
study (Table 1).
3.2. Longitudinal effects
Depressed patients treated with ECT showed significant volu-
metric increases in several cortical and subcortical regions at T2, T3
and T4 (pFDR < 0.05) (Fig. 1A, Table 2). After the first ECT session
(T2), the brain stem, the bilateral hippocampi, left thalamus proper,
right putamen, right inferior lateral ventricle, right banks of the
superior temporal sulcus, right lateral occipital cortex, right lingual
gyrus and right middle temporal gyrus showed significant volume
increases as compared with baseline volumes.
After the end of the treatment series (T3), significant changes
were broadly distributed both in cortical and subcortical regions
(pFDR < 0.05). In the cortex, all regions showed significant increases,
except for bilateral frontal poles, left medial and lateral orbito-
frontal cortex, left pars orbitalis of the inferior frontal gyrus, right
isthmus cingulate and pericalcarine cortex. Among subcortical re-
gions, thalamus, caudate, putamen, pallidum, hippocampus,
amygdala and nucleus accumbens volumes were bilaterally
increased, while ventral diencephalon volume increase was sig-
nificant only on the right side. No significant changes were
demonstrated for cerebral white matter, cerebellum white matter
and cortex and brain stem volumes at T3. All the ventricles, except
the fourth, showed significant volume decreases. After six months
from the end of the treatment (T4), the right amygdala volume
increase was still significant after FDR correction, while left
amygdala, entorhinal cortex bilaterally, right temporal pole and
right lateral ventricle showed significant increases at the uncor-
rected level (see Table 2).
HC did not show significant volume changes after FDR correc-
tion at any time point (Fig. 1B, Supplementary Table 1). Similarly,
patients treated with ECV did not show significant volume changes
after correction for multiple comparisons (Supplementary Table 2).
3.3. Longitudinal comparisons
Among significant volumetric increases observed in depressed
patients after the first ECT session (T2), changes in the brain stem,
in right inferior lateral ventricle and in the right banks of the su-
perior temporal sulcus were significantly greater than in HC and
ECV controls. In addition, changes in left thalamus proper, right
lateral occipital cortex and right middle temporal gyrus were
significantly greater than in HC, while changes in left hippocampus
and right putamen were significantly greater than in ECV controls.
Right hippocampus and right lingual gyrus and changes were not
significantly different among groups (Table 3). No significant
changes between HC and ECV controls were observed.
Table 1
Characteristics of the samples.
ECT patients n HC n ECV patients n
Age Mean (SD) 46.42 (15.18) 34 42.83 (15.88) 18 65.50 (6.48) 16
Sex Females (%) 18 (52.9) 34 11 (61.1%) 18 1 (6.3%) 16
T1 (time of day, hours) Median (IQR) 8.00 (0.17) 34 8.00 (0.00) 18 8.83 (0.42) 16
T2 (time of day, hours) Median (IQR) 12.00 (0.00) 33 12.00 (0.00) 18 15.15 (0.25) 16
T3 (time of day, hours) Median (IQR) 9.25 (2.00) 29 8.00 (1.63) 16 e
T4 (time of day, hours) Median (IQR) 9.00 (1.69) 22 8.08 (1.75) 16 e
T2-T1 (hours) Median (IQR) 4.00 (0.17) 33 4.00 (0.00) 18 6.48 (0.36) 16
T3-T1 (days) Mean (SD) 39.93 (15.26) 29 46.88 (14.15) 16 e
T4-T1 (days) Median (IQR) 207 (37) 22 202.33 (20.10) 16 e
Episode duration (months) Median (IQR) 8.25 (14.65) 32 e e
ECT sessions (number) Mean (SD) 10.97 (4.11) 32 e e
MADRST1 Mean (SD) 33.59 (4.94) 34 e e
MADRST3 Mean (SD) 15.40 (8.32) 33 e e
MADRST4 Mean (SD) 14.45 (12.09) 20 e e
Antidepressants Number using during ECT (%) 23 (68) 34
Antipsychotics Number using during ECT (%) 23 (68) 34
Antiepileptics Number using during ECT (%) 3 (8.8) 34
Lithium salts Number using during ECT (%) 3 (8.8) 34
Benzodiazepines Number using during ECT (%) 1 (2.9) 34
ECT charge at first treatment (mC) Mean (SD) 228 (84) 34
ECT charge at last treatment (mC) Mean (SD) 253 (108) 34
Response (MADRST3 change  50%) Number at T3 (%) 20 (60.6) 33
Remission (MADRST3 < 10) Number at T3 (%) 11 (33.3) 33
Psychotic depression Number at inclusion (%) 3 (8.8) 34
Bipolar depression Number at inclusion (%) 7 (21) 34
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weeks after the end of the ECT series in depressed patients, were
significantly different from those observed in HC at the same
timepoint (T3). All the volumetric increases in subcortical regions
were greater in ECT patients than in HC, except than for the left
pallidum changes whose difference only approached statistical
significance (p ¼ 0.078). Similarly, all the volumetric decreases inFig. 1. Mean volume changes (%) from baseline approximately 2 h after the first ECT session
patients (A) and HC (B). Significant findings which survived FDR correction are highlighted
with low transparency, not significant changes with high transparency. Abbreviations: L ¼ l
cerebral white matter; 2 ¼ L lateral ventricle; 3 ¼ L inf lat vent; 4 ¼ L cerebellum white matte
pallidum; 10 ¼ third 3rd ventricle; 11 ¼ forth 4th ventricle; 12 ¼ brain stem; 13 ¼ L hippocampus
18 ¼ R lateral ventricle; 19 ¼ R inf lat vent; 20 ¼ R cerebellum white matter; 21 ¼ R cerebellum c
hippocampus; 27 ¼ R amygdala; 28 ¼ R accumbens area; 29 ¼ R ventraldc; 30 ¼ Lh bankssts;
entorhinal; 35 ¼ Lh fusiform; 36 ¼ Lh inferiorparietal; 37 ¼ Lh inferiortemporal; 38 ¼ Lh isthmu
medialorbitofrontal; 43 ¼ Lh middletemporal; 44 ¼ Lh parahippocampal; 45 ¼ Lh paracentral
calcarine; 50 ¼ Lh postcentral; 51 ¼ Lh posteriorcingulate; 52 ¼ Lh precentral; 53 ¼ Lh precuneu
57 ¼ Lh superiorparietal; 58 ¼ Lh superiortemporal; 59 ¼ Lh supramarginal; 60 ¼ Lh frontalpo
65 ¼ Rh caudalanteriorcingulate; 66 ¼ Rh caudalmiddlefrontal; 67 ¼ Rh cuneus; 68 ¼ Rh en
isthmuscingulate; 73 ¼ Rh lateraloccipital; 74 ¼ Rh lateralorbitofrontal; 75 ¼ Rh lingual; 76
paracentral; 80 ¼ Rh parsopercularis; 81 ¼ Rh parsorbitalis; 82 ¼ Rh parstriangularis; 83 ¼ Rh p
precuneus; 88 ¼ Rh rostralanteriorcingulate; 89 ¼ Rh rostralmiddlefrontal; 90 ¼ Rh superiorfron
frontalpole; 95 ¼ Rh temporalpole; 96 ¼ Rh transversetemporal; 97 ¼ Rh insula. (For interpretat
of this article.)
1333the ventricles were significantly more pronounced in ECT patients
than in HC. In the right hemisphere approximately two thirds of
volume increases observed after ECT were significantly greater
than in HC. Frontal and parietal gyri, the cuneus, precentral and
supramarginal gyri made exceptions (Table 3). Conversely, statis-
tically significant differences in left hemispherewere found only for
caudal anterior and posterior cingulate cortex, cuneus, entorhinal(T2, 1), one week after the end of ECT course (T3, 2) and six months after (T4, 3) in ECT
in opaque colours, significant findings which did not survive FDR correction are shown
eft; R ¼ right; Lh ¼ left cortical hemisphere; Rh ¼ right cortical hemisphere. Legend: 1 ¼ L
r; 5 ¼ L cerebellum cortex; 6 ¼ L thalamus proper; 7 ¼ L caudate; 8 ¼ L putamen; 9 ¼ L
; 14 ¼ L amygdala; 15 ¼ L accumbens area; 16 ¼ L ventraldc; 17 ¼ R cerebral white matter;
ortex; 22 ¼ R thalamus proper; 23 ¼ R caudate; 24 ¼ R putamen; 25 ¼ R pallidum; 26 ¼ R
31 ¼ Lh caudalanteriorcingulate; 32 ¼ Lh caudalmiddlefrontal; 33 ¼ Lh cuneus; 34 ¼ Lh
scingulate; 39 ¼ Lh lateraloccipital; 40 ¼ Lh lateralorbitofrontal; 41 ¼ Lh lingual; 42 ¼ Lh
; 46 ¼ Lh parsopercularis; 47 ¼ Lh parsorbitalis; 48 ¼ Lh parstriangularis; 49 ¼ Lh peri-
s; 54 ¼ Lh rostralanteriorcingulate; 55 ¼ Lh rostralmiddlefrontal; 56 ¼ Lh superiorfrontal;
le; 61 ¼ Lh temporalpole; 62 ¼ Lh transversetemporal; 63 ¼ Lh insula; 64 ¼ Rh bankssts;
torhinal; 69 ¼ Rh fusiform; 70 ¼ Rh inferiorparietal; 71 ¼ Rh inferiortemporal; 72 ¼ Rh
¼ Rh medialorbitofrontal; 77 ¼ Rh middletemporal; 78 ¼ Rh parahippocampal; 79 ¼ Rh
ericalcarine; 84 ¼ Rh postcentral; 85 ¼ Rh posteriorcingulate; 86 ¼ Rh precentral; 87 ¼ Rh
tal; 91 ¼ Rh superiorparietal; 92 ¼ Rh superiortemporal; 93 ¼ Rh supramarginal; 94 ¼ Rh
ion of the references to colour in this figure legend, the reader is referred to the Web version
Table 2
Patients’ volume changes from baseline approximately 2 h after the first ECT session (T2), one week after the end of ECT course (T3) and six months after (T4). Significant
findings which survived FDR correction are highlighted in bold. Legend numbers from Fig. 1 are also reported (#). Abbreviations: ROI ¼ region of interest; SD ¼ standard de-
viation; L ¼ left; R ¼ right; Lh ¼ left cortical hemisphere; Rh ¼ right cortical hemisphere.













# Mean SD t p Mean SD t p Mean SD t p
L cerebral white matter 1 0.00 0.33 0.05 0.956 0.05 0.51 0.49 0.626 0.07 0.52 0.61 0.552
L cerebellum white matter 4 0.07 0.47 0.90 0.372 0.05 0.51 0.57 0.573 0.07 0.63 0.51 0.619
L cerebellum cortex 5 0.08 0.32 1.42 0.166 0.11 0.59 1.01 0.320 0.10 0.85 0.49 0.632
L thalamus proper 6 0.29 0.56 3.01 0.005 0.90 0.81 5.99 0.000 0.10 0.61 0.71 0.490
L caudate 7 0.39 0.91 2.49 0.018 1.14 1.30 4.73 0.000 0.13 1.09 0.49 0.633
L putamen 8 0.31 0.60 2.93 0.006 0.70 1.01 3.74 0.001 0.12 0.88 0.57 0.574
L pallidum 9 0.23 0.93 1.44 0.161 0.58 0.78 4.04 0.000 0.03 0.83 0.17 0.867
L hippocampus 13 0.86 1.36 3.65 0.001 1.95 1.97 5.33 0.000 0.48 1.41 1.44 0.169
L amygdala 14 0.09 1.90 0.26 0.793 2.53 2.48 5.49 0.000 0.86 1.36 2.68 0.016
L accumbens area 15 0.03 1.49 0.12 0.907 0.97 2.22 2.35 0.026 0.07 1.88 0.16 0.878
L ventraldc 16 0.10 0.80 0.70 0.488 0.23 0.76 1.65 0.109 0.01 0.78 0.05 0.958
R cerebral white matter 17 0.01 0.30 0.21 0.836 0.11 0.49 1.15 0.258 0.03 0.53 0.25 0.804
R cerebellum white matter 20 0.06 0.40 0.93 0.359 0.07 0.48 0.73 0.472 0.22 0.58 1.61 0.125
R cerebellum cortex 21 0.13 0.49 1.46 0.153 0.15 0.63 1.27 0.215 0.01 1.04 0.03 0.975
R thalamus proper 22 0.22 0.58 2.15 0.039 1.22 1.19 5.52 0.000 0.02 0.84 0.10 0.925
R caudate 23 0.26 0.59 2.52 0.017 1.12 1.22 4.91 0.000 0.02 0.98 0.09 0.930
R putamen 24 0.40 0.55 4.16 0.000 1.45 1.00 7.75 0.000 0.12 0.86 0.57 0.573
R pallidum 25 0.26 0.89 1.67 0.104 0.90 1.03 4.70 0.000 0.31 0.81 1.62 0.124
R hippocampus 26 0.73 1.20 3.51 0.001 2.99 1.88 8.54 0.000 0.65 1.43 1.93 0.070
R amygdala 27 0.43 1.45 1.69 0.101 6.04 3.35 9.70 0.000 2.18 1.56 5.94 0.000
R accumbens area 28 0.23 1.54 0.86 0.394 1.97 2.51 4.23 0.000 0.09 1.58 0.24 0.810
R ventraldc 29 0.22 0.64 1.96 0.059 0.53 0.91 3.15 0.004 0.21 0.82 1.09 0.293
brain stem 12 0.29 0.45 3.73 0.001 0.21 0.72 1.60 0.122 0.16 0.82 0.83 0.420
L lateral ventricle 2 1.17 3.10 2.17 0.037 3.68 7.74 2.56 0.016 2.95 6.25 2.01 0.061
L inf lat vent 3 1.56 4.38 2.05 0.048 3.77 7.70 2.64 0.013 0.79 5.64 0.60 0.558
R lateral ventricle 18 0.95 3.21 1.69 0.100 5.10 7.47 3.68 0.001 3.49 5.94 2.50 0.023
R inf lat vent 19 2.50 4.06 3.53 0.001 5.91 12.39 2.57 0.016 0.23 3.68 0.26 0.798
3rd ventricle 10 0.83 3.84 1.24 0.225 5.06 7.57 3.60 0.001 1.46 5.64 1.09 0.289
4th ventricle 11 0.87 3.79 1.32 0.196 1.36 4.40 1.66 0.108 0.61 3.09 0.84 0.412
Lh banks sts 30 0.45 0.92 2.80 0.009 0.88 1.23 3.86 0.001 0.11 1.31 0.36 0.723
Lh caudal anterior cingulate 31 0.11 1.23 0.52 0.603 1.87 1.26 7.97 0.000 0.32 1.15 1.17 0.256
Lh caudal middle frontal 32 0.03 0.86 0.23 0.816 1.13 1.68 3.61 0.001 0.23 1.61 0.60 0.559
Lh cuneus 33 0.17 0.6 1.60 0.119 0.53 0.75 3.82 0.001 0.17 0.74 0.96 0.350
Lh entorhinal 34 0.51 2.73 1.08 0.289 1.66 2.45 3.64 0.001 1.00 1.49 2.85 0.011
Lh fusiform 35 0.28 0.94 1.69 0.101 0.98 1.06 4.94 0.000 0.15 0.89 0.70 0.494
Lh inferior parietal 36 0.32 0.76 2.46 0.019 0.98 1.39 3.80 0.001 0.25 1.56 0.67 0.513
Lh inferior temporal 37 0.08 0.84 0.54 0.592 0.83 1.23 3.66 0.001 0.22 1.23 0.76 0.458
Lh isthmus cingulate 38 0.21 0.92 1.31 0.200 0.57 1.12 2.77 0.010 0.14 1.00 0.61 0.547
Lh lateral occipital 39 0.29 0.66 2.51 0.017 0.61 0.94 3.49 0.002 0.01 0.99 0.06 0.954
Lh lateral orbitofrontal 40 0.21 1.09 1.10 0.279 0.55 1.44 2.07 0.048 0.32 1.12 1.23 0.237
Lh lingual 41 0.38 0.76 2.85 0.008 0.55 0.67 4.38 0.000 0.14 0.82 0.70 0.491
Lh medial orbitofrontal 42 0.13 0.73 1.02 0.315 0.42 1.11 2.01 0.054 0.03 0.85 0.16 0.876
Lh middle temporal 43 0.03 1.07 0.16 0.870 0.81 1.59 2.77 0.010 0.43 1.23 1.47 0.161
Lh parahippocampal 44 0.15 0.97 0.87 0.392 1.09 1.43 4.12 0.000 0.04 0.85 0.19 0.854
Lh paracentral 45 0.08 0.83 0.52 0.605 1.19 1.22 5.26 0.000 0.10 1.31 0.34 0.742
Lh parsopercularis 46 0.07 0.72 0.53 0.598 1.32 1.57 4.53 0.000 0.13 1.11 0.49 0.632
Lh parsorbitalis 47 0.30 1.75 1.00 0.326 0.51 2.63 1.05 0.304 0.43 1.51 1.19 0.249
Lh parstriangularis 48 0.21 1.16 1.05 0.303 1.27 2.21 3.09 0.004 0.17 1.59 0.46 0.653
Lh pericalcarine 49 0.32 0.71 2.56 0.015 0.55 0.96 3.07 0.005 0.39 0.99 1.65 0.117
Lh postcentral 50 0.03 0.97 0.17 0.869 0.81 1.52 2.89 0.007 0.17 1.74 0.43 0.675
Lh posterior cingulate 51 0.15 0.78 1.13 0.267 0.78 1.02 4.13 0.000 0.28 0.75 1.60 0.128
Lh precentral 52 0.05 0.56 0.53 0.600 1.01 1.31 4.17 0.000 0.05 1.44 0.14 0.893
Lh precuneus 53 0.11 0.51 1.22 0.232 0.81 0.77 5.65 0.000 0.04 0.81 0.19 0.849
Lh rostral anterior cingulate 54 0.19 0.83 1.35 0.186 0.73 1.17 3.39 0.002 0.10 1.20 0.35 0.732
Lh rostral middle frontal 55 0.14 0.96 0.87 0.391 0.93 1.61 3.12 0.004 0.08 1.30 0.27 0.793
Lh superior frontal 56 0.06 0.94 0.34 0.737 1.09 1.56 3.77 0.001 0.15 0.97 0.67 0.509
Lh superior parietal 57 0.04 0.65 0.37 0.713 0.69 1.06 3.54 0.001 0.20 1.32 0.63 0.538
Lh superior temporal 58 0.23 1.13 1.16 0.256 1.10 1.70 3.47 0.002 0.01 0.94 0.04 0.970
Lh supramarginal 59 0.14 1.04 0.76 0.452 1.14 1.48 4.15 0.000 0.12 1.48 0.34 0.738
Lh frontal pole 60 0.29 1.64 1.01 0.318 0.18 2.89 0.34 0.736 0.49 1.56 1.32 0.203
Lh temporal pole 61 0.02 2.34 0.04 0.967 1.99 3.03 3.53 0.001 0.21 2.17 0.40 0.691
Lh transverse temporal 62 0.47 0.93 2.89 0.007 0.90 1.61 2.99 0.006 0.30 1.51 0.86 0.404
Lh insula 63 0.12 0.77 0.93 0.360 1.46 1.39 5.65 0.000 0.16 0.96 0.68 0.509
Rh banks sts 64 0.82 0.98 4.80 0.000 1.61 1.67 5.18 0.000 0.21 1.13 0.79 0.443
Rh caudal anterior cingulate 65 0.04 1.01 0.23 0.817 1.91 1.45 7.07 0.000 0.05 1.48 0.15 0.880
Rh caudal middle frontal 66 0.07 0.79 0.49 0.626 1.00 1.13 4.78 0.000 0.20 2.00 0.42 0.677
Rh cuneus 67 0.28 0.68 2.35 0.025 0.48 0.88 2.93 0.007 0.10 0.66 0.67 0.512
Rh entorhinal 68 0.19 1.49 0.73 0.470 2.94 3.14 5.05 0.000 1.32 2.11 2.66 0.017
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# Mean SD t p Mean SD t p Mean SD t p
Rh fusiform 69 0.21 0.63 1.93 0.063 1.51 1.29 6.30 0.000 0.10 1.02 0.43 0.673
Rh inferior parietal 70 0.38 0.84 2.57 0.015 1.07 1.27 4.51 0.000 0.17 1.18 0.61 0.550
Rh inferior temporal 71 0.28 0.63 2.57 0.015 1.70 1.40 6.53 0.000 0.08 1.25 0.27 0.791
Rh isthmus cingulate 72 0.29 0.83 2.02 0.052 0.36 0.97 1.99 0.056 0.13 0.99 0.55 0.587
Rh lateral occipital 73 0.41 0.66 3.63 0.001 0.97 0.99 5.30 0.000 0.02 0.97 0.09 0.929
Rh lateral orbitofrontal 74 0.28 1.21 1.32 0.196 1.05 1.50 3.78 0.001 0.37 1.38 1.13 0.275
Rh lingual 75 0.37 0.65 3.25 0.003 0.77 0.95 4.36 0.000 0.15 0.69 0.93 0.368
Rh medial orbitofrontal 76 0.20 0.73 1.60 0.120 0.89 1.32 3.63 0.001 0.17 1.10 0.65 0.527
Rh middle temporal 77 0.56 1.00 3.19 0.003 1.56 1.69 4.97 0.000 0.20 1.44 0.61 0.553
Rh parahippocampal 78 0.07 1.03 0.41 0.687 2.06 1.77 6.26 0.000 0.36 1.17 1.29 0.214
Rh paracentral 79 0.10 0.70 0.85 0.404 1.08 1.22 4.75 0.000 0.06 1.14 0.21 0.835
Rh parsopercularis 80 0.16 0.73 1.23 0.228 1.11 1.58 3.78 0.001 0.10 1.08 0.39 0.705
Rh parsorbitalis 81 0.17 1.48 0.65 0.518 0.98 2.13 2.49 0.019 0.06 1.48 0.16 0.873
Rh parstriangularis 82 0.43 1.06 2.36 0.025 1.09 1.81 3.24 0.003 0.06 1.69 0.15 0.885
Rh pericalcarine 83 0.34 0.85 2.31 0.028 0.31 1.01 1.65 0.111 0.08 0.90 0.37 0.717
Rh postcentral 84 0.18 0.67 1.54 0.134 0.94 1.03 4.90 0.000 0.06 1.18 0.21 0.834
Rh posterior cingulate 85 0.13 0.69 1.07 0.294 0.72 1.21 3.21 0.003 0.17 1.23 0.60 0.554
Rh precentral 86 0.14 0.67 1.19 0.241 0.98 1.36 3.88 0.001 0.01 1.49 0.04 0.972
Rh precuneus 87 0.03 0.53 0.35 0.731 0.73 0.83 4.75 0.000 0.05 0.97 0.21 0.839
Rh rostral anterior cingulate 88 0.26 0.73 2.07 0.047 1.78 1.48 6.48 0.000 0.02 1.22 0.08 0.937
Rh rostral middle frontal 89 0.35 1.03 1.93 0.062 0.99 1.73 3.07 0.005 0.05 1.48 0.13 0.898
Rh superior frontal 90 0.04 0.90 0.25 0.808 1.16 1.71 3.66 0.001 0.16 1.65 0.42 0.678
Rh superior parietal 91 0.04 0.63 0.35 0.729 0.76 1.04 3.94 0.000 0.17 1.12 0.64 0.530
Rh superior temporal 92 0.41 0.84 2.84 0.008 2.27 1.68 7.28 0.000 0.19 1.31 0.63 0.539
Rh supramarginal 93 0.28 0.91 1.76 0.089 1.41 1.60 4.75 0.000 0.17 1.22 0.61 0.550
Rh frontal pole 94 0.34 2.17 0.89 0.379 1.01 3.28 1.66 0.108 0.28 2.20 0.54 0.599
Rh temporal pole 95 0.20 2.05 0.56 0.577 4.13 2.84 7.85 0.000 1.40 2.35 2.54 0.021
Rh transverse temporal 96 0.35 1.01 1.97 0.057 1.30 1.43 4.89 0.000 0.06 1.13 0.23 0.822
Rh insula 97 0.05 0.77 0.37 0.711 2.50 1.46 9.24 0.000 0.10 1.25 0.34 0.737
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gyri and the insula. Finally, after six months from the end of the
treatment (T4), the right amygdala volume increase observed in
patients having received ECT was significantly more pronounced
than changes observed in HC (mean difference ¼ 1.91, t ¼ 3.45,
p ¼ 0.002).3.4. Association between volume changes at successive timepoints
Volume changes at the end of the ECT series (T3) were signifi-
cantly positively predicted by volume changes after the first
treatment (T2) in some cortical regions, namely in the temporal
pole and superior frontal gyrus bilaterally, in caudal middle frontal
gyrus, pars orbitalis and triangularis of the inferior frontal gyrus,
precentral and postcentral gyri, supramarginal gyrus, and ento-
rhinal cortex in the left hemisphere, in frontal pole, lateral orbito-
frontal cortex and rostral middle frontal gyrus in the right
hemisphere, both according to unadjusted and adjusted linear
model controlling for the number of ECT sessions (pFDR < 0.05)
(Supplementary Table 3). However, when including among pre-
dictors an interaction between volume changes at T2 and number
of sessions, no significant predictors of volume changes at T3 were
found. Number of ECT sessions were not found to predict volume
changes after the end of treatment (T3) in any model.
Volumetric changes after six months from the end of the
treatment (T4) were significantly positively predicted by volume
changes at T3 in several cortical and subcortical ROIs (pFDR < 0.05)
(Supplementary Table 3). In the cortex, changes at T3 and T4 were
significantly correlated bilaterally in the frontal pole, superior
frontal gyrus, the three parts of the inferior frontal gyrus, precentral
and postcentral gyri, superior parietal gyrus, superior, middle and1335transverse temporal gyri, insula, parahippocampal cortex, posterior
cingulate cortex and precuneus; on the left side in the temporal
pole, inferior temporal gyrus, lateral occipital and pericalcarine
cortex; on the right side in rostral middle frontal gyrus, medial
orbitofrontal cortex, paracentral cortex, rostral and caudal anterior
cingulate cortex. In addition, volume changes were significantly
positively correlated bilaterally in the putamen, amygdala and
ventral diencephalon, cerebral white matter, lateral ventricles and
fourth ventricle, but also in the left pallidum and left cerebellum
cortex and in the right thalamus proper.
3.5. Cross-sectional comparisons
Before the first treatment (T1), depressed patients showed
significantly smaller volumes than HC in the left parahippocampal
cortex (pFDR < 0.05). After the first treatment (T2), significant dif-
ferences were still found in the same region, while differences
between patients and HC in left parahippocampal cortex detected
at the end of the treatment (T3) and after six months (T4) did not
survived correction for multiple comparisons (Supplementary
Table 4).
3.6. Exploratory associations with clinical scores
None of the significant treatment-related volume changes
observed at T2 were found to predict depression severity decrease
at the end of the treatment (MADRST3-T1), EMQ change and AMI-SF
consistency at T3. Significant correlations between volume changes
and clinical scores at the end of treatment (T3) were found instead
(Supplementary Table 5). None of these results were corrected for
multiple testing.
Table 3
Comparisons of volume changes among ECT patients, HC and ECV patients at T2, and
between ECT patients and HC at T3. Only significant pairwise mean differences
between groups are shown, based on Tukey's post-hoc test at T2 and two-sample t-
test at T3. Abbreviations: ROI ¼ region of interest; SD ¼ standard deviation; L ¼ left;
R ¼ right; Lh ¼ left cortical hemisphere; Rh ¼ right cortical hemisphere; NS ¼ not
significant.
T2: 33 ECT vs. 18
HC vs. 16 ECV
Mean differences
ROI F p ECT - HC ECT - ECV
L thalamus proper 3.90 0.024 0.40 NS
L hippocampus 5.50 0.006 NS 1.10
R putamen 4.60 0.013 NS 0.50
R hippocampus 2.40 0.098 NS NS
brain stem 6.70 0.002 0.40 0.40
R inf lat vent 6.30 0.003 2.70 3.40
Rh banks sts 5.80 0.005 0.90 0.80
Rh lateral occipital 4.40 0.017 0.40 NS
Rh lingual 2.90 0.064 NS NS
Rh middle temporal 4.60 0.013 0.70 NS
T3: 29 ECT vs. 16
HC
Mean differences
ROI t p ECT - HC ECT - ECV
L thalamus proper 4.52 0.000 0.94 -
L caudate 3.26 0.002 1.18 -
L putamen 3.02 0.004 0.66 -
L pallidum 1.82 0.078 NS -
L hippocampus 4.79 0.000 1.93 -
L amygdala 4.30 0.000 2.35 -
L accumbens area 2.54 0.015 1.20 -
R thalamus proper 4.74 0.000 1.20 -
R caudate 3.33 0.002 1.05 -
R putamen 6.89 0.000 1.59 -
R pallidum 3.25 0.002 0.75 -
R hippocampus 7.89 0.000 3.20 -
R amygdala 9.19 0.000 6.08 -
R accumbens area 3.39 0.002 1.93 -
R ventraldc 3.33 0.002 0.74 -
L lateral ventricle 2.22 0.032 3.84 -
L inf lat vent 1.68 0.100 NS -
3rd ventricle 3.34 0.002 6.10 -
R lateral ventricle 3.14 0.003 5.03 -
R inf lat vent 2.18 0.036 5.28 -
Lh banks sts 0.73 0.469 NS -
Lh caudal anterior cingulate 4.84 0.000 1.77 -
Lh caudal middle frontal 0.85 0.402 NS -
Lh cuneus 2.12 0.040 0.40 -
Lh entorhinal 2.51 0.016 1.47 -
Lh fusiform 3.16 0.003 0.84 -
Lh inferior parietal 0.89 0.382 NS -
Lh inferior temporal 1.18 0.246 NS -
Lh isthmus cingulate 1.73 0.092 NS -
Lh lateral occipital 1.26 0.218 NS -
Lh lingual 2.74 0.009 0.48 -
Lh middle temporal 0.19 0.849 NS -
Lh parahippocampal 2.40 0.022 0.93 -
Lh paracentral 4.10 0.000 1.15 -
Lh pars opercularis 1.39 0.176 NS -
Lh pars triangularis 0.98 0.334 NS -
Lh pericalcarine 1.66 0.104 NS -
Lh postcentral 0.50 0.619 NS -
Lh posterior cingulate 2.72 0.009 0.69 -
Lh precentral 0.99 0.331 NS -
Lh precuneus 2.80 0.009 0.70 -
Lh rostral anterior cingulate 0.99 0.329 NS -
Lh rostral middle frontal 0.53 0.602 NS -
Lh superior frontal 0.92 0.367 NS -
Lh superior parietal 0.94 0.359 NS -
Lh superior temporal 0.75 0.460 NS -
Lh supra marginal 0.01 0.995 NS -
Lh temporal pole 1.33 0.194 NS -
Lh transverse temporal 1.90 0.065 NS -
Lh insula 3.24 0.002 1.21 -
Rh banks sts 3.05 0.004 1.46 -
Rh caudal anterior cingulate 3.97 0.000 1.79 -
Rh caudal middle frontal 0.79 0.438 NS -
Rh cuneus 1.57 0.124 NS -
Table 3 (continued )
T2: 33 ECT vs. 18
HC vs. 16 ECV
Mean differences
ROI F p ECT - HC ECT - ECV
Rh entorhinal 3.97 0.000 2.86 -
Rh fusiform 4.11 0.000 1.25 -
Rh inferior parietal 1.41 0.169 NS -
Rh inferior temporal 4.39 0.000 1.58 -
Rh lateral occipital 3.64 0.001 0.79 -
Rh lateral orbitofrontal 3.33 0.002 1.21 -
Rh lingual 3.39 0.002 0.74 -
Rh medial orbitofrontal 2.09 0.044 0.78 -
Rh middle temporal 2.60 0.014 1.44 -
Rh parahippocampal 4.68 0.000 2.04 -
Rh paracentral 3.09 0.004 1.09 -
Rh pars opercularis 1.90 0.065 NS -
Rh pars orbitalis 1.08 0.290 NS -
Rh pars triangularis 1.37 0.182 NS -
Rh postcentral 2.26 0.031 0.78 -
Rh posterior cingulate 2.35 0.024 0.75 -
Rh precentral 1.44 0.161 NS -
Rh precuneus 2.34 0.027 0.67 -
Rh rostral anterior cingulate 3.34 0.002 1.59 -
Rh rostral middle frontal 0.62 0.543 NS -
Rh superior frontal 1.43 0.163 NS -
Rh superior parietal 1.33 0.193 NS -
Rh superior temporal 4.28 0.000 2.20 -
Rh supra marginal 1.82 0.082 NS -
Rh temporal pole 3.36 0.002 3.07 -
Rh transverse temporal 4.24 0.000 1.44 -
Rh insula 7.89 0.000 2.57 -
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latedwithMADRST3-T1 (B¼ 2.94, p¼ 0.003) alsowhen adjusting for
the number of ECT sessions (B¼ 2.93, p¼ 0.004); i.e. the greater the
volume increase, the lesser the decrease in depression severity.
Volume increase in left caudal anterior cingulate cortex was also
significantly positively associated with MADRST3-T1, but only when
not adjusting for the number of sessions (B¼ 3.82, p¼ 0.041). Right
lateral and medial orbitofrontal cortex volume increases were
negatively correlated with EMQT3-T1 (B ¼ 14.78, p ¼ 0.013;
B ¼ 11.79, p ¼ 0.040), also when adjusting for the number of
treatments (B ¼ 14.75, p ¼ 0.016; B ¼ 11.74, p ¼ 0.047); i.e. the
greater the increase, the greater the reduction of subjective mem-
ory complaints. In addition, only when adjusting for the number of
ECTs, left superior parietal gyrus volume increase was found to be
positively correlated with AMI-SF consistency at T3 (B ¼ 6.11,
p ¼ 0.037); i.e. the greater the volume increase, the higher the
consistency in autobiographical memory. Finally, volume increases
in right thalamus proper (B¼ 0.12, p¼ 0.024), left paracentral gyrus
(B ¼ 0.13, p ¼ 0.020) and right postcentral gyrus (B ¼ 0.11,
p ¼ 0.021) were significantly positively predicted by the number of
treatments, while a negative association was found with volume
change in right inferior lateral ventricle (B ¼ 1.24, p ¼ 0.026). No
significant associations between right amygdala volume increase
and clinical scores at T4 were detected (Supplementary Table 5).4. Discussion
To the best of our knowledge, this is the first study investigating
immediate volumetric effects of ECT. A trend toward volume in-
crease was already observable in most regions after approximately
2 h from the first ECT session, with significant results in the brain
stem, the bilateral hippocampi, right putamen and left thalamus
and temporal and occipital regions in the right hemisphere. As far
as we know, increased hippocampus and amygdala volumes have
previously been reported after the second ECT session [20], but no
G.E. Brancati, N. Brekke, H. Bartsch et al. Brain Stimulation 14 (2021) 1330e1339study has investigated the immediate effects of a single ECT session.
Such changes were not observed in HC, nor in patients receiving
anesthesia for ECV. Notably, the immediate effects of ECT were
significantly correlated with volume changes after the end of
treatment only in a few cortical regions of interest, and no signifi-
cant interactionswith number of ECT sessions were detected, thus a
linear cumulative process of the immediate effects seems unlikely
as the underlying mechanism for volume increases induced by the
ECT series. Indeed, for ROIs representing the cerebral ventricles, the
volume changes at T2 and T3 were opposite, while no changes in
subcortical regions after ECT were predicted by immediate effects.
Moreover, it is noteworthy that, among others, volumetric in-
creases in the brain stem were significantly more pronounced in
ECT patients in comparison with both HC and ECV patients, thus
being probably independent from time-of-day effects and anes-
thesia effects. Importantly, brain stem changes were transient and
could not be observed at later timepoints. They may be related to
the mechanisms underlying generalized seizure induction given
the role of the reticular formation in tonic-clonic seizures genera-
tion [36,37], but also to the enhancement of serotonergic and
dopaminergic neurotransmission observed after ECS/ECT [8].
Other studies have examined short-term changes in T1 and T2
relaxation time to clarify whether ECT could induce a breakdown in
the blood-brain barrier and subsequent changes in brain water
content, variably interpreted as edema and/or increased blood flow.
Mander and colleagues were the first to observe an increase in T1
relaxation time of a brain transverse section within 1 h after the
first and last ECT session [38]. Significant transient increases in T1
relaxation time were later confirmed in non-dominant cerebral
hemisphere both 25 min and 2 h after ECT [39]. A non-significant
rise in T2 relaxation time was also observed, reaching its
maximum at 2 h after ECT [39]. Increased T2 relaxation time were
also reported in medial temporal lobes and thalamus approxi-
mately 2-2½ hours after ECT, with significant differences in the
thalami between 1 and 2 days before the first session and 2-2½
hours after the second one [40]. However, more recent studies by
Girish et al. failed to replicate increases in T2 relaxation time
measured bilaterally in thalamus, hippocampus, medial temporal
lobes and dorsolateral frontal cortex one day before the first ECT
and 2 h after the second session [41,42]. Given the inconsistency of
previous results and the small sample sizes, no conclusions could
be drawn to infer a role of increased water content in the volu-
metric increases observed in our study 2 h after ECT. Interestingly,
in a subgroup of patients included in this study, we observed an
increase in isotropic hindered diffusion in white matter extra-
neurite water compartment 2 h after the first ECT, which could
stem from an increase in water content [43]. A localized vasogenic
edema could be excluded, at least in the hippocampus, where a
decrease in mean diffusivity has been repeatedly observed
[44e46], at later stages of treatment (i.e. observed within oneweek
from the end of ECT series).
More consistent results have been obtained from animal studies
on ECS. Indeed, neurogenesis, gliogenesis and angiogenesis
demonstrated in rats receiving both acute and chronic ECS, have
been proposed to underlie the volumetric increases observed in
patients treated with ECT [12]. However, the possibility of neuro-
plasticity underlying the immediate volumetric effects observed in
our study seems implausible. In the first report on ECS-induced
neurogenesis in the dentate gyrus of rats, maximal cell prolifera-
tion seemed to occur on days 3 and 5 after the administration of a
single ECS, without increases in the first 12 h [13]. The seizure-
induced proliferation of neural progenitors in dentate gyrus also
overlaps in time with that of glial progenitors [14]. Endothelial and
neural proliferation in the dentate gyrus have also been shown to
occur in concert, with significant increase in endothelial cells1337proliferation on the second day after a single ECS, but not at day 0,
4, 6 or 8, and increased number of proliferating cluster (endothelial
plus neural) cells in the subgranular zone at days 2 through 6,
peaking at day 4 [15]. Conversely, transient morphological changes
associated with glial cells activation have been shown to occur as
early as 2 h after the last of a series of ECS, with microglial cells,
astrocytes and NG2-positive glial cells showing thicker and slightly
shortened processes and larger cell bodies [47]. However, even
though changes in glial number and morphology, together with
axon sprouting, dendritic branching and synaptogenesis, have been
proposed as cellular events underlying gray matter changes
detected by MRI [48], studies are needed in order to elucidate the
relationship betweenmicro- andmacrostructural events, especially
in such a limited timeframe. Indeed, glial activation, cerebral edema
and blood-brain barrier permeability changes are likely to co-occur
and have been repeatedly observed after inflammatory acute in-
sults originated outside the brain [49]. The short-term volumetric
effects observed in our study could thus also be interpreted in light
of the hypothesis proposed by Van Buel and colleagues, which
posits that inflammatory response, mainly induced in the periph-
ery minutes to hours after single ECT sessions, could mobilize
neurotrophin expression and endogenous neuroprotection [11].
Neuroinflammation is less likely to explain the volume changes
observed at 6 months. In particular, the right amygdala volume
increase was still significant and most cortical and subcortical
volumes were still increased, including in the left amygdala and
temporal cortical regions. Interestingly, volume increase after 7e14
days from the last ECT session was more pronounced in the right
amygdala, which also showed the greatest (and the only signifi-
cant) increase after 6 months. On the other hand, in many regions,
the greater changes after 6 months were observed in patients with
greater changes at the end of the ECT series, suggesting the possi-
bility of durable influences on brain structure. In animal models,
newborn cells after a single ECS were found to differentiate and
survive for at least 3 months and the number of neurons formed
was positively correlated with the number of ECS trials adminis-
tered [13], resembling the relationship observed between response
probability and number of treatments in humans [50]. Increased
gray matter volumes in the long-term could thus be explained by
the neurotrophic effects which would underlie volume increases at
the end of the treatment course. Long-term changes in gray matter
volumes after ECT have also been recently reported in temporal
regions by Gyger and colleagues [51]. Nonetheless, our findings
should be considered preliminary and warrant replication from
other samples or multi-site investigations. Even though a correc-
tion for multiple comparisons was applied to longitudinal analyses
to reduce the risk of false positive error, the small sample size and
the high number of ROIs still suggest caution in interpreting these
results.
Surprisingly, after the end of ECT treatment, volume increases in
the amygdala and in the anterior cingulate cortex were negatively
associated with depression outcome, with a greater increase in
volume corresponding to a lesser decrease in depression severity.
However, these findings seem questionable in light of the null
correlations between volume change and ECT outcome observed in
the more powered GEMRIC study [18]. Similarly, some exploratory
associations between volume increases after the ECT course and
changes in subjective memory complaints or autobiographical
memory consistency were observed, respectively in the right
orbitofrontal cortex and in the left superior parietal gyrus, which, if
replicated, could warrant some more attention. However, given the
high number of models tested and the uncorrected level of signif-
icance, also these findings should be interpreted with caution.
Indeed, despite recent findings of a significant association between
hippocampal volume change and cognitive impairments [52,53],
G.E. Brancati, N. Brekke, H. Bartsch et al. Brain Stimulation 14 (2021) 1330e1339no relationship between hippocampal volume increase and sub-
jective and autobiographic memory measures was observed in our
study.
Some other limitations should be acknowledged. The samples
were not perfectly matched in terms of gender, age and time of
scan. In comparison with ECT patients, HC were more frequently
females and ECV patients were mostly male. These latter were also
older in comparison with ECT patients and were scanned at
different times. Unfortunately, the anesthetic used was different
between ECT and ECV patients. However, our main analysis was
focused on changes within subjects, and we controlled for age and
gender in cross-sectional comparisons.5. Conclusions
In our study, we evaluated the timing of volume changes
induced in cortical and subcortical regions by ECT in depressed
patients scanned 2 h before and after their first ECT session, 7e14
days after the end of the ECT series and at 6 months follow-up. As
expected based on the recent GEMRIC results [18], widespread
volume increases were observed in both cortical and subcortical
areas after the whole course of ECT. More interestingly, volume
increaseswere also observed approximately 2 h after the first ECTe
excluding neurogenesis as the underlying mechanism. Further-
more, volume increase remained in the amygdala 6 months after
the end of treatment, implying that different biological mecha-
nisms could be in play at different time points. In future human and
animal studies focusing on brain micro- and macrostructural
changes induced by ECT, more attention should be given to the
timing of changes observed and different approaches should be
encouraged to elucidate the relationship between molecular and
cellular processes and their morphological correlates.Funding
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